Navigation Links
Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
Date:9/24/2008

American Association for Cancer Research Aims to Raise Awareness about the Importance of Clinical Trial Participation

PHILADELPHIA, Sept. 24 /PRNewswire/ --

News facts:

-- Most Americans with cancer would be receptive to participating in

clinical trials if they knew about them.

-- In a survey of 6,000 cancer patients, 85 percent were either unaware

or unsure that participation in a clinical trial was an option.

Seventy-five percent said they would have been willing to enroll had

they known it was possiblei.

-- This lack of knowledge is leading to a crisis in cancer drug

development with 80 percent of clinical trials in the U.S. being

delayed because of unfulfilled enrollmentii.

-- While clinical trials remain the only way to effectively test potential

new medications, fewer than 5 percent of adult cancer patients

participate in themiii. This lack of participation leads to delays in

clinical trials and slows patient access to new and possibly lifesaving

treatment options.

-- The American Association for Cancer Research (AACR), the proud

scientific partner of Stand Up to Cancer, a ground-breaking initiative

aimed at raising funds to accelerate cancer research and bringing new

therapies to patients more quickly, is committed to spreading knowledge

about cancer research and is on the front lines of the quest for

prevention and cure. AACR is taking a lead in raising awareness about

the urgent need to increase cancer clinical trial participation.

-- Clinical trials are not for everyone, but if you have been diagnosed

with any type of cancer, talk to your doctor about whether a clinical

trial may be right for you.

-- For information about AACR's progress toward the prevention and

cure of cancer, please visit http://www.aacr.org.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/aacr/35116/

Commentary on clinical trials:

"The American Association for Cancer Research aims to educate the public about what a clinical trial can offer and ensure people know all of their treatment options, including clinical trials, at the time of their diagnosis. Through this process patients can make an educated decision when choosing their course of therapy with their doctor." - Raymond N. DuBois, M.D., Ph.D. President, AACR and Provost and Executive Vice President of Academic Affairs, M. D. Anderson Cancer Center

"The challenge is to make patients and healthcare providers more aware of clinical trials. While more funds for research are needed, progress also requires more participation in clinical trials." - Gwen Darien, Director of Survivor and Patient Advocacy, AACR

"Cancer patients need to ask their doctors about clinical trials. It's important to be proactive and find out about treatment options and decide which is right for you." - Connie Mielich, cancer survivor and clinical trial participant

"The care I received while participating in a clinical trial was the best I've ever had. The healthcare providers were very attentive to my needs. Some patients may have reservations about enrolling but I advise people to ask their doctor about clinical trials and discuss it with their loved ones." - Connie Mielich, cancer survivor and clinical trial participant

About the AACR

Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research and the prevention and cure of cancer. The membership includes more than 28,000 basic, translational, and clinical researchers, healthcare professionals' cancer survivors and advocates in the United States and 80 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs.

i Harris Interactive survey - data on file

ii CISCRP's 101 Facts About Clinical Research: Treatment & Cures of Disease." The Center for Information & Study on Clinical Research Participation. July 2007. http://www.ciscrp.org/information/documents/101FactsaboutClinicalResearch.p df (16 Jan. 2008).

iii Lara P, et al. "Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment." The Journal of Clinical Oncology 19(2001):1728-1733.


'/>"/>
SOURCE American Association for Cancer Research (AACR)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden ... Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price Analysis ... the global Fibromyalgia market. The research answers the following ... for Fibromyalgia and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... LA JOLLA, Calif. , Feb. 23, 2017 /PRNewswire/ ... biopharmaceutical company leading the discovery and development of innovative ... quarter and full year 2016 financial results on Thursday, ... Regulus will host a conference call and webcast on ... discuss fourth quarter and full year 2016 financial results ...
Breaking Medicine Technology:
(Date:2/24/2017)... Abilene, Texas (PRWEB) , ... February 24, 2017 , ... ... article that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an ... of this current generation. He explains that the Bible details the current times ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Country Club in Miami Beach to host its Swirl: Miami Wine Tasting Event ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):